Sca-1 / c-Kit receptor expression and apoptosis pattern in ENU induced MDS mice
- PMID: 20720596
Sca-1 / c-Kit receptor expression and apoptosis pattern in ENU induced MDS mice
Abstract
The bone marrow is the major site of haemopoiesis in adult human. It contains cells that represent the stages in the development of different types of blood cells e.g. myelocytes, metamyelocytes, erythroblasts, reticulocytes, and other lymphoid progenies etc. Bone marrow failure is primarily the result of a specific failure of bone marrow precursor cells to produce mature cells. N-ethyl N-nitroso urea (ENU) is one of the most potent mutagens that can create an abnormal bone marrow microenvironment by causing defect in haematopoietic stem cell maturation cascade. ENU is easy to administer in mouse, and some probable mutations can be helpful to create models of human diseased conditions like Myelodysplastic syndrome (MDS). MDS is considered as an intravascular bone marrow disorder, a combined structural-functional abnormality wherein the differentiation procedure of the bone marrow stem cell is either incomplete or defective. We assumed that Myelodysplastic syndrome stands in between an inhibitory cellular pattern and a positive overshoot of abnormal differentiations representing an unknown juncture where the mystery of aplasia and leukemia hide back. Instead of using a transgenic mouse model, we attempted to develop an experimentally induced murine model of preleukemia or human MDS like disease model. In doing so ENU has been administered i.p and the animals were examined on thirtieth day and peripheral blood haemogram was documented. Upon registering the appearance of abnormal peripheral blood scenario, the changes in the intravascular bone marrow (BM) architecture, cell surface receptor expression, e.g. Sca-1, c-Kit and the early and late phase apoptic patterns were noted. The results represented an interesting correlation in between bone marrow architecture, early stem cell receptor and apoptic marker expression resembling human MDS.
Similar articles
-
Physician Education: Myelodysplastic Syndrome.Oncologist. 1996;1(4):284-287. Oncologist. 1996. PMID: 10388004
-
Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation.J Stem Cells. 2009;4(3):179-89. J Stem Cells. 2009. PMID: 20232602
-
Evaluation of Sca-1 and c-Kit as selective markers for muscle remodelling by nonhemopoietic bone marrow cells.Stem Cells. 2007 Jun;25(6):1364-74. doi: 10.1634/stemcells.2006-0194. Epub 2007 Feb 15. Stem Cells. 2007. PMID: 17303817
-
Lingering biologic dilemmas about the status of the progenitor cells in myelodysplasia.Arch Med Res. 2003 Nov-Dec;34(6):515-9. doi: 10.1016/j.arcmed.2003.09.001. Arch Med Res. 2003. PMID: 14734091 Review.
-
Mouse models of myelodysplastic syndromes.Leuk Res. 2011 Jul;35(7):853-62. doi: 10.1016/j.leukres.2011.03.007. Epub 2011 Apr 3. Leuk Res. 2011. PMID: 21466894 Review.
Cited by
-
The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment.Mol Cell Biochem. 2021 Feb;476(2):535-551. doi: 10.1007/s11010-020-03920-6. Epub 2020 Oct 4. Mol Cell Biochem. 2021. PMID: 33011884
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous